Dhana Klodian, Koolhaas Chantal M, van Rossum Elisabeth F C, Ikram M Arfan, Hofman Albert, Kavousi Maryam, Franco Oscar H
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
PLoS One. 2016 Apr 21;11(4):e0154273. doi: 10.1371/journal.pone.0154273. eCollection 2016.
Whether being metabolically healthy obese (MHO)-defined by the presence of obesity in the absence of metabolic syndrome-is associated with subsequent cardiovascular disease (CVD) remains unclear and may depend on the participants' age. We examined the association of being MHO with CVD risk in the elderly.
This study included 5,314 individuals (mean age 68 years) from the prospective population-based Rotterdam Study. We categorized our population in groups according to body mass index (BMI) and presence and absence of metabolic syndrome, and estimated the hazard ratio (HR) and 95% confidence interval (95%CI) for every group by using Cox proportional hazard models. Among 1048 (19.7%) obese individuals we identified 260 (24.8%) MHO subjects. Over 14 years of follow-up there were 861 incident CVD cases. In the multivariable adjusted analysis, we did not observe an increased CVD risk in MHO individuals (HR 1.07, 95%CI 0.75-1.53), compared to normal weight individuals without metabolic syndrome. CVD risk was increased by the presence of metabolic syndrome in normal weight (HR 1.35, 95%CI 1.02-1.80), overweight (HR 1.32, 95%CI 1.09-1.60) and obese (HR 1.33, 95%CI 1.07-1.66) individuals, compared to those with normal weight without metabolic syndrome. In a mediation analysis, 71.3% of the association between BMI and CVD was explained by the presence of metabolic syndrome.
In our elderly population, we found that the presence of obesity without metabolic syndrome did not confer a higher CVD risk. However, metabolic syndrome was strongly associated with CVD risk, and was associated with an increased risk in all BMI categories. Therefore, preventive interventions targeting cardiometabolic risk factors could be considered in elderly, regardless of weight status.
代谢健康型肥胖(MHO)定义为存在肥胖但无代谢综合征,其是否与后续心血管疾病(CVD)相关仍不清楚,且可能取决于参与者的年龄。我们研究了老年人中MHO与CVD风险的关联。
本研究纳入了基于鹿特丹研究的前瞻性人群中的5314名个体(平均年龄68岁)。我们根据体重指数(BMI)以及代谢综合征的有无将人群分组,并使用Cox比例风险模型估计每组的风险比(HR)和95%置信区间(95%CI)。在1048名(19.7%)肥胖个体中,我们识别出260名(24.8%)MHO受试者。在14年的随访期间,有861例新发CVD病例。在多变量调整分析中,与无代谢综合征的正常体重个体相比,我们未观察到MHO个体的CVD风险增加(HR 1.07,95%CI 0.75 - 1.53)。与无代谢综合征的正常体重个体相比,正常体重(HR 1.35,95%CI 1.02 - 1.80)、超重(HR 1.32,95%CI 1.09 - 1.60)和肥胖(HR 1.33,95%CI 1.07 - 1.66)个体中代谢综合征的存在会增加CVD风险。在中介分析中,BMI与CVD之间71.3%的关联可由代谢综合征的存在来解释。
在我们的老年人群中,我们发现无代谢综合征的肥胖存在并不会带来更高的CVD风险。然而,代谢综合征与CVD风险密切相关,且在所有BMI类别中均与风险增加相关。因此,无论体重状况如何,均可考虑针对老年人心血管代谢危险因素进行预防性干预。